Atlas Venture Fund IX, L.P.'s Net Worth
$150 Million
Who is Atlas Venture Fund IX, L.P.?
Atlas Venture Fund IX, L.P. has an estimated net worth of $150 Million. This is based on reported shares across multiple companies, which include Intellia Therapeutics, Inc., Unum Therapeutics Inc., Spero Therapeutics, Inc., Surface Oncology, Inc., and SYNLOGIC, INC..
SEC CIK
Atlas Venture Fund IX, L.P.'s CIK is 0001671219
Past Insider Trading and Trends
2018 was Atlas Venture Fund IX, L.P.'s most active year for acquiring shares with 5 total transactions. Atlas Venture Fund IX, L.P.'s most active month to acquire stocks was the month of March. 2016 was Atlas Venture Fund IX, L.P.'s most active year for disposing of shares, totalling 4 transactions. Atlas Venture Fund IX, L.P.'s most active month to dispose stocks was the month of April. 2018 saw Atlas Venture Fund IX, L.P. paying a total of $2,628,624.00 for 6,643,352 shares, this is the most they've acquired in one year. In 2020 Atlas Venture Fund IX, L.P. cashed out on 3,400,000 shares for a total of $44,540,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75
InvestorAtlas Venture Fund IX, L.P. owns 3,579,788 units of Common Stock which is worth $70,700,813.00. In the year 2016 Atlas Venture Fund IX, L.P. filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.02% | -150.00K |
$16.24 | -$2,435,440.00 | 3.58M |
Jul 7 - Jul 11
| |||
Form 4
| -15.80% | -700.00K |
—
|
—
| 3.73M |
Mar 3
| |||
Form 4
|
∞
| 4.43M |
—
|
—
| 4.43M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Unum Therapeutics Inc. (COGT) Snapshot price: $10.47
InvestorAtlas Venture Fund IX, L.P. owns 3,361,535 units of Common Stock which is worth $35,195,271.45. In the year 2018 Atlas Venture Fund IX, L.P. filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.36M |
$12.00 |
—
| 3.36M |
Apr 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.3101
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surface Oncology, Inc. No price found
InvestorAtlas Venture Fund IX, L.P. owns 2,945,453 units of Common Stock. In the year 2018 Atlas Venture Fund IX, L.P. filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -36.59% | -1.70M |
$8.10 | -$13,770,000.00 | 2.95M |
Dec 17
| |||
Form 4
| -36.59% | -1.70M |
$18.10 | -$30,770,000.00 | 2.95M |
Dec 17
| |||
Form 4
| +240.67% | 3.28M |
$15.00 |
—
| 4.65M |
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SYNLOGIC, INC. (SYBX) Snapshot price: $1.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||